Pooling of Prospective Studies of Diet, Lifestyle and ALS

饮食、生活方式和 ALS 前瞻性研究的汇集

基本信息

  • 批准号:
    8237375
  • 负责人:
  • 金额:
    $ 17.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-30 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): To investigate prospectively the role of diet and lifestyle as risk factors of amyotrophic lateral sclerosis (ALS), we propose to pool the primary data of the Pooling Project of Prospective Studies of Diet and Cancer (Cancer Pooling Project), an international consortium of 28 cohort studies. A number of risk factors for sporadic ALS have been examined epidemiologically, mainly in retrospective case-control studies: smoking, exposure to metals or solvents, trauma, and diet. Findings, however, have been inconsistent and may be subject to bias; retrospective case-control studies of long-term diet are particularly prone to recall bias. Previous findings need to be confirmed in rigorous prospective studies, but the low incidence of ALS makes prospective analyses a challenge. The existing consortium is a uniquely valuable resource for meeting that challenge; we need only collect information on ALS. The proposed project is thus an unusual opportunity for efficient scientific investigation, providing a unique opportunity to circumvent the main limitations of epidemiologic studies of ALS to-date -- poor power and retrospective design -- in the hope to elucidate the etiology of this devastating and fatal disease. The dietary aims of this project are to examine the relation between dietary intake of fatty acids, antioxidants and flavonoids, and fruit and vegetables with ALS. The non-dietary aims are to investigate the association between body-mass index (BMI) and physical activity and ALS. A secondary aim is to confirm the associations reported between smoking behavior and risk of ALS, including evaluating whether there is a lack of a dose- response in pack-years, cigarettes smoked per day and time since quitting smoking. In addition, any interesting leads that may emerge from preliminary analyses will be pursued. The main strengths of the proposed investigation are its prospective design and the efficient use of existing data from ongoing international studies. Because ALS is a relatively rare disease, a prospective investigation of ALS would require very large populations and long periods of follow-up, at a considerable cost. By taking advantage of well characterized cohorts participating in the Cancer Pooling Project that have accumulated many years of follow-up, the cost and time can be cut to a small fraction. The independent population made from the collaborating cohorts will comprise 450,657 women and 195,097 men with over 652 ALS deaths from the outset of the project (ALS deaths will continue to be accrued throughout the project duration). PUBLIC HEALTH RELEVANCE: Because ALS is a rare disease, we propose to merge data from a series of international studies to investigate whether diet and lifestyle behaviors are risk factors. Each of the studies included have collected comprehensive information on diet and lifestyle factors, like smoking and body mass index, before the participants had symptoms of their disease. We will use these data to see if any of the factors confer a higher or lower risk of ALS on participants. Finding such associations could aid our understanding of the origins of this disease or translate into a change in the approach to its treatment.
描述(申请人提供):为了前瞻性地调查饮食和生活方式作为肌萎缩侧索硬化症(ALS)危险因素的作用,我们建议汇集饮食和癌症前瞻性研究的汇集项目(癌症汇集项目)的原始数据,该项目是一个由28项队列研究组成的国际联盟。对散发性肌萎缩侧索硬化症的一些危险因素进行了流行病学研究,主要是在回溯性病例对照研究中:吸烟、接触金属或溶剂、创伤和饮食。然而,研究结果并不一致,可能会有偏差;对长期饮食的回溯性病例对照研究特别容易出现回忆偏差。以前的发现需要在严格的前瞻性研究中得到证实,但ALS的低发病率使前瞻性分析成为一个挑战。现有的联盟是应对这一挑战的独特宝贵资源;我们只需要收集有关肌萎缩侧索硬化症的信息。因此,拟议的项目是一个有效的科学调查的不同寻常的机会,提供了一个独特的机会,以绕过迄今为止ALS流行病学研究的主要局限性--能力差和回溯性设计--希望阐明这种毁灭性和致命疾病的病因。这个项目的饮食目标是研究饮食中脂肪酸、抗氧化剂和类黄酮类的摄入量与患有肌萎缩侧索硬化症的水果和蔬菜之间的关系。非饮食目的是调查身体质量指数(BMI)与体力活动和ALS之间的关系。第二个目标是确认吸烟行为和肌萎缩侧索硬化症风险之间的联系,包括评估是否缺乏包年数、每天吸烟的香烟和戒烟后的时间的剂量反应。此外,将追查从初步分析中可能出现的任何有趣的线索。拟议调查的主要优点是其前瞻性设计和有效利用正在进行的国际研究的现有数据。由于肌萎缩侧索硬化症是一种相对罕见的疾病,对肌萎缩侧索硬化症的前瞻性研究需要非常大的人群和长期的随访,成本相当高。通过利用参与癌症汇集项目的具有良好特征的队列,这些队列已经积累了多年的随访,成本和时间可以被削减到一小部分。从合作队列中获得的独立人口将包括450,657名女性和195,097名男性,自项目开始以来,有超过652人死于肌萎缩侧索硬化症(在整个项目期间,肌萎缩侧索硬化症死亡人数将继续增加)。 公共卫生相关性:由于ALS是一种罕见的疾病,我们建议合并一系列国际研究的数据,以调查饮食和生活方式行为是否是危险因素。纳入的每项研究都收集了关于饮食和生活方式因素的全面信息,如吸烟和体重指数,在参与者出现疾病症状之前。我们将使用这些数据来观察是否有任何因素会使参与者患ALS的风险更高或更低。发现这种联系可以帮助我们了解这种疾病的起源,或者转化为治疗方法的改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eilis O'Reilly其他文献

Eilis O'Reilly的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eilis O'Reilly', 18)}}的其他基金

Pooling of Prospective Studies of Diet, Lifestyle and ALS
饮食、生活方式和 ALS 前瞻性研究的汇集
  • 批准号:
    8338797
  • 财政年份:
    2011
  • 资助金额:
    $ 17.66万
  • 项目类别:
Pooling of Prospective Studies of Diet, Lifestyle and ALS
饮食、生活方式和 ALS 前瞻性研究的汇集
  • 批准号:
    8471214
  • 财政年份:
    2011
  • 资助金额:
    $ 17.66万
  • 项目类别:

相似海外基金

Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
  • 批准号:
    MR/Y014901/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
  • 批准号:
    MR/Y014286/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
  • 批准号:
    MR/Y503502/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
  • 批准号:
    2317745
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
  • 批准号:
    10759808
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
  • 批准号:
    10848139
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
  • 批准号:
    10606865
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
  • 批准号:
    488892
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
  • 批准号:
    MR/Y001095/1
  • 财政年份:
    2023
  • 资助金额:
    $ 17.66万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了